6,030
Views
18
CrossRef citations to date
0
Altmetric
Addendum

Insights from pharmacokinetic models of host-microbiome drug metabolism

ORCID Icon, ORCID Icon & ORCID Icon
Pages 587-596 | Received 15 Jul 2019, Accepted 10 Sep 2019, Published online: 29 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Amina Džidić-Krivić, Jasna Kusturica, Emina Karahmet Sher, Nejra Selak, Nejra Osmančević, Esma Karahmet Farhat & Farooq Sher. (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metabolism Reviews 55:1-2, pages 126-139.
Read now
Laura E. McCoubrey, Moe Elbadawi, Mine Orlu, Simon Gaisford & Abdul W. Basit. (2021) Harnessing machine learning for development of microbiome therapeutics. Gut Microbes 13:1.
Read now

Articles from other publishers (16)

Cleo Demeester, Donnia Robins, Angela Elma Edwina, Jos Tournoy, Patrick Augustijns, Ibrahim Ince, Andreas Lehmann, Maria Vertzoni & Jan Frederik Schlender. (2023) Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review. European Journal of Pharmaceutical Sciences 188, pages 106496.
Crossref
Jingwei Cai, Alexis Auster, Sungjoon Cho & Zijuan Lai. (2023) Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage. Journal of Advanced Research.
Crossref
Gabriele Conti, Federica D’Amico, Marco Fabbrini, Patrizia Brigidi, Monica Barone & Silvia Turroni. (2022) Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. Genes 14:1, pages 55.
Crossref
Liu Liu, Yiming Liu, Xiaojie Zhou, Zhiwei Xu, Yehui Zhang, Liting Ji, Chunlan Hong & Changyu Li. (2022) Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap. Frontiers in Pharmacology 13.
Crossref
Brian D. Chapron, Alenka Chapron & J. Steven Leeder. (2021) Recent advances in the ontogeny of drug disposition. British Journal of Clinical Pharmacology 88:10, pages 4267-4284.
Crossref
Sandrayee Brahma, Amruta Naik & Ronan Lordan. (2022) Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?. Clinical Nutrition ESPEN 51, pages 17-27.
Crossref
Abdelrahman Saqr, Brooke Carlson, Christopher Staley, Armin Rashidi, Mahmoud Al-Kofahi, Thomas Kaiser, Shernan Holtan, Margaret MacMillan, Jo-Anne Young, Najla El Jurdi, Daniel Weisdorf, Alexander Khoruts & Pamala A. Jacobson. (2022) Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 28:7, pages 372.e1-372.e9.
Crossref
Zhenhui Liu, Sheetal Parida, Shaoguang Wu, Cynthia L. Sears, Dipali Sharma & Ishan Barman. (2022) Label-Free Vibrational and Quantitative Phase Microscopy Reveals Remarkable Pathogen-Induced Morphomolecular Divergence in Tumor-Derived Cells. ACS Sensors 7:5, pages 1495-1505.
Crossref
Xueshu Li, Joe Jongpyo Lim, Kai Wang, Bhagwat Prasad, Deepak K. Bhatt, Julia Yue Cui & Hans-Joachim Lehmler. (2022) The disposition of polychlorinated biphenyls (PCBs) differs between germ-free and conventional mice. Environmental Toxicology and Pharmacology 92, pages 103854.
Crossref
Suqing Zheng, Lei Wang, Jun Xiong, Guang Liang, Yong Xu & Fu Lin. (2022) Consensus Prediction of Human Gut Microbiota-Mediated Metabolism Susceptibility for Small Molecules by Machine Learning, Structural Alerts, and Dietary Compounds-Based Average Similarity Methods. Journal of Chemical Information and Modeling 62:4, pages 1078-1099.
Crossref
Jordina Balaguer-Trias, Deepika Deepika, Marta Schuhmacher & Vikas Kumar. (2022) Impact of Contaminants on Microbiota: Linking the Gut–Brain Axis with Neurotoxicity. International Journal of Environmental Research and Public Health 19:3, pages 1368.
Crossref
Laura E. McCoubrey, Stavriani Thomaidou, Moe Elbadawi, Simon Gaisford, Mine Orlu & Abdul W. Basit. (2021) Machine Learning Predicts Drug Metabolism and Bioaccumulation by Intestinal Microbiota. Pharmaceutics 13:12, pages 2001.
Crossref
Maria Zimmermann-Kogadeeva. (2021) Quantifying host-microbiota interactions. Science 373:6551, pages 173-173.
Crossref
Michael Zimmermann, Kiran Raosaheb Patil, Athanasios Typas & Lisa Maier. (2021) Towards a mechanistic understanding of reciprocal drug–microbiome interactions. Molecular Systems Biology 17:3.
Crossref
Assunta Liberti, Ojas Natarajan, Celine Grace F. Atkinson, Paolo Sordino & Larry J. Dishaw. (2021) Reflections on the Use of an Invertebrate Chordate Model System for Studies of Gut Microbial Immune Interactions. Frontiers in Immunology 12.
Crossref
Hendrik Neubert, Stephen C Alley, Anita Lee, Wenying Jian, Michael Buonarati, Anna Edmison, Fabio Garofolo, Boris Gorovits, Sam Haidar, Bill Mylott, Parya Nouri, Mark Qian, Stephen Vinter, Troy Voelker, Jan Welink, Jiang Wu, Eric Yang, Hongbin Yu, Chris Evans, Scott Summerfield, Jian Wang, Kevin Bateman, Jason Boer, Brian Dean, Lieve Dillen, Patrick Faustino, Luca Ferrari, Nicola Hughes, Lina Luo, Timothy Olah, Noah Post, Daniel S. Spellman, Jens Sydor, Hui Zhang, Jenny Zhang, Jinhui Zhang, Christine Fandozzi, Amanda Wilson, Daniela Fraier, Christopher J. Beaver, Suman Dandamudi, Arindam Dasgupta, Rebecca Elliott, Allena Ji, Wenkui Li, Michael McGuinness, Gustavo Mendes Lima Santos, Tahseen Mirza, Natasha Savoie, Diaa Shakleya, Sune Sporring, Susan Stojdl, Phillip Sundman, Nilufer Tampal & Eric Woolf. (2021) 2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome ( Part 1 – Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos) . Bioanalysis 13:4, pages 203-238.
Crossref